Bank of New York Mellon Corp/The (BNY)
Key Takeaways:
Valuation Metrics
BNY trades at P/E (ttm) 16.84 and Forward P/E 14.09, implying the market expects earnings growth and a modestly improving earnings power versus last year.
The PEG 0.91 is below 1, suggesting the current valuation is reasonable relative to expected growth (supports both value and growth frameworks).
Price multiples versus income statement drivers: P/S 2.42 and P/C 61.64 (note: P/C is unusually large/indicative of how cash flow is being treated in the dataset; treat this metric cautiously).
Balance-sheet-based valuation: P/B 2.46 is relatively elevated for a value investor, but for high-quality financials it can be justified when ROE/ROIC are strong (see profitability section).
Cash-flow efficiency: P/FCF 61.64 in the dataset appears very high/possibly distorted by low or volatile free cash flow. Use with caution; it does not scream “cheap” on this metric.
Enterprise valuation: EV/EBITDA 14.22 and EV/Sales 8.40 indicate a mid-to-slightly-priced-in multiple regime rather than deep value.
Earnings & Profitability
EPS (ttm) 8.59 with EPS next Y 10.26 signals expected earnings expansion; EPS this Y 8.59 → next Y 10.26 supports a growth narrative.
Earnings momentum indicators: EPS Y/Y (ttm) 24.98% suggests strong recent profitability improvement (positive for both value (quality) and growth).
For “surprise” potential: EPS/Sales Surprise 14.87% indicates recent beats (good sign for earnings quality and estimate revisions).
Margins: ROA 1.59% and ROE 1.96% are shown in the dataset as decimals; however, the provided ROIC 0.68 and margin fields (Oper. Margin 19.32%, Profit Margin 14.87%) indicate profitability strength. For financials, interpret ROA/ROE carefully but the operating/profit margin metrics look solid.
Operating and profitability mix: Oper. Margin 26.82% and Profit Margin 14.87% (as provided) support that earnings are not purely financial/one-off—BNY appears to be generating meaningful operating profitability.
Growth Analysis
Consensus growth expectations look constructive: EPS next Y +19.27% (10.26 vs 8.59) and EPS next 5Y 10.98% implies durable mid-teens-to-high-single growth potential depending on how the series is modeled.
Past trend: EPS past 3/5Y 14.10% indicates historical earnings compounding above many mature financials—supports a growth thesis.
Revisions/estimate trajectory: EPS next Q 2.27 and EPS this Y 1.59 (as provided) plus positive EPS Q/Q 10.98% suggests near-term stabilization and growth cadence.
Sales growth: Sales Y/Y (ttm) 10.26% and Sales past 3/5Y 10.31% show revenue growth consistent with earnings growth (quality growth, not just margin compression).
Market’s growth-to-price balance: PEG 0.91 reinforces that growth is not massively “overpriced.”
Financial Health
Leverage: Debt/Eq 0.68 and LT Debt/Eq 0.61 suggest moderate leverage for a bank holding structure.
Liquidity: Quick Ratio 1.60 and Current Ratio 1.94 indicate adequate short-term coverage capacity.
Balance sheet buffers: Cash/sh 0.25 (dataset units) appears modest; however, for banks, liquidity and capital adequacy are more directly reflected by regulatory ratios (not provided here).
Profitability supports solvency: stronger operating/profit margins (provided) align with stable capital generation.
Overall: based on the available ratios, BNY looks financially healthy (liquidity and moderate leverage), but full bank safety assessment would require capital and asset-quality metrics not included in this dataset.
Ownership Structure
Insider activity: Insider Own 0.25% (low insider ownership), which is common for large financial institutions.
Insider transactions: Insider Trans -4.88% (as provided), suggesting modest net selling or reduced insider buying—does not automatically negate the thesis but is not a strong buy signal.
Institutional ownership: Inst Own 87.74% with Inst Trans -1.40%. High institutional ownership supports liquidity and quality, while slightly negative institutional activity can indicate caution but may also reflect normal rebalancing.
Net: ownership structure looks typical for a large-cap bank; institutional backing is a positive stabilizer for both value and growth investors.
Market Performance
Current price/level: Price 146.98 vs Prev Close 144.63 (Change +1.60%), indicating near-term positive trading action.
52-week range: 52W High 169.50, 52W Low 146.98—BNY is essentially at/near the 52-week low, which is notable for value setups (entry risk/reward can be attractive).
Trend in simple moving averages (SMA): Price 146.98 is above SMA20 144.63, below/near depending on SMA50 146.98 (equal) and far below SMA200 103.11? (dataset shows SMA200 103.11; with price 146.98, price is actually well above SMA200, suggesting a longer-term uptrend despite being near 52W lows).
Relative performance context: provided Perf 1Y -? (not cleanly parsed), but multi-horizon returns show mixed momentum: Perf Quarter +40.27% and Perf YTD -12.79% (mixed signal—bounce after a weaker YTD).
Momentum & Volatility
Volatility: Volatility 21.92% and ATR (14) 3.06 indicate moderate day-to-day price movement for a large-cap financial.
Beta: Beta 1.25 suggests above-market sensitivity to broader equity movements.
RSI: RSI (14) 40.27 indicates the stock is in a mildly weak momentum zone (not deeply oversold, but not overbought).
Short interest: Short Float 1.52% and Short Ratio 1.60 (low-to-moderate). This reduces likelihood of a major short-squeeze catalyst.
Relative volume: Rel Volume 1.94 and Avg Volume 10.31M with Volume 165.84 (dataset shows an outlier formatting; treat as potentially inconsistent). Still, the presence of above-average activity around the current move suggests active participation.
Price action context: near the 52W low with RSI below 50 generally improves asymmetric entry potential for value investors, while growth investors should monitor whether earnings estimates keep trending upward.
Investment Recommendations
value Investor:
Target a buy zone around $140–$146, with a more opportunistic tranche closer to $135–$140. Rationale: BNY is near the 52W low (146.98) and RSI ~40 suggests weakness; value investors typically want a margin of safety versus the current valuation regime (P/E ~16.8, P/B ~2.46).
growth Investor:
Target a buy zone around $145–$150 if earnings revisions continue. Rationale: valuation is fairly reasonable (PEG ~0.91, forward P/E 14.09) and EPS is expected to grow (EPS next Y 10.26; EPS next 5Y 10.98%). If price rebounds toward the low-mid 150s without a deterioration in forward EPS, it can still be a growth-appropriate entry.
Investment Summary
BNY screens as reasonably valued for growth (Forward P/E 14.09, PEG 0.91) with earnings momentum (EPS Y/Y ~24.98%) and supportive medium-term expectations (EPS next 5Y ~10.98%). Financial health looks adequate (moderate leverage; liquidity ratios >1). Price is near the 52W low with RSI ~40, improving value entry asymmetry. Value: buy $140–$146 (deeper $135–$140). Growth: $145–$150 if estimates keep rising.
